NCT00447018

Brief Summary

The purpose of this study is to determine whether mannitol is as effective as hypertonic saline solution in the treatment of elevated intracranial pressure in patients with brain injury.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Oct 2002

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2002

Completed
2.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2005

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

March 12, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 13, 2007

Completed
Last Updated

March 13, 2007

Status Verified

March 1, 2007

First QC Date

March 12, 2007

Last Update Submit

March 12, 2007

Conditions

Keywords

intracranial pressuremannitolhypertonic saline solutionbrain injurytraumatic brain injuryAdult patientsWith elevation of intracranial pressure (ICP > 20 mmHg)

Outcome Measures

Primary Outcomes (1)

  • Magnitude of ICP and of cerebral perfusion pressure (CPP) changes following osmotherapy during a study period of 120 min.

Secondary Outcomes (3)

  • Effects of treatment on blood flow velocities (FV) of middle cerebral artery using continuous transcranial doppler.

  • Effects of treatment on brain oxygenation using brain tissue oxygen tension (PbrO2) probe.

  • Effects of treatment on biochemical data (serum sodium and osmolality, urine output).

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18 or older
  • sustained elevated intracranial pressure to more than 20 mmHg for more than 10 min
  • mechanically ventilated in stable conditions for more than 2 hours prior to the study
  • serum osmolality ranged between 280 and 320 mOsm/kg

You may not qualify if:

  • imminent cranial or extracranial surgery
  • leakage or drainage of cerebral spinal fluid
  • unstable respiratory and hemodynamic conditions
  • oliguric renal failure
  • anemia
  • use of mannitol or HSS in the previous 6 hours
  • concomitant use of thiopentone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Michallon

Grenoble, 38043, France

Location

Related Publications (2)

  • Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med. 2005 Jan;33(1):196-202; discussion 257-8. doi: 10.1097/01.ccm.0000150269.65485.a6.

  • Vialet R, Albanese J, Thomachot L, Antonini F, Bourgouin A, Alliez B, Martin C. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med. 2003 Jun;31(6):1683-7. doi: 10.1097/01.CCM.0000063268.91710.DF.

MeSH Terms

Conditions

Intracranial HypertensionBrain InjuriesBrain Injuries, Traumatic

Interventions

MannitolSaline Solution, Hypertonic

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Sugar AlcoholsAlcoholsOrganic ChemicalsCarbohydratesHypertonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Jean-Francois Payen, MD, PhD

    University Hospital, Grenoble

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 12, 2007

First Posted

March 13, 2007

Study Start

October 1, 2002

Study Completion

June 1, 2005

Last Updated

March 13, 2007

Record last verified: 2007-03

Locations